PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-15

  1. 200 Posts.
    lightbulb Created with Sketch. 42
    Yep, it's all well and good to read the well put together research from Mozz, but that is all irrelevant given it's the now that matters and if the board don't get serious about this, there will be no tomorrow to look forward to for us shareholders.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.